Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - CAPITAL EXPENDITURES
Capital Expenditures ALNY - Alnylam Pharmaceuticals, Inc.
-62.2 M
LAST VALUE
9.75%
2 YEAR CAGR
13.29%
5 YEAR CAGR
-31.56%
10 YEAR CAGR